Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(33)
DRUG(13)
PROCEDURE(5)
BIOLOGICAL(2)
Total-Body Irradiation
5 trials
phase_1phase_2
nohla-therapeutics-inc, fred-hutchinson-cancer-center
Umbilical Cord Blood Transplantation
4 trials
phase_2
fred-hutchinson-cancer-center, nohla-therapeutics-inc
Cyclophosphamide
4 trials
phase_1phase_2
nohla-therapeutics-inc, fred-hutchinson-cancer-center
Thiotepa
3 trials
phase_2
nohla-therapeutics-inc, fred-hutchinson-cancer-center
Cyclosporine
3 trials
phase_1phase_2
fred-hutchinson-cancer-center, nohla-therapeutics-inc
Mycophenolate Mofetil
3 trials
phase_1phase_2
fred-hutchinson-cancer-center, nohla-therapeutics-inc
Fludarabine
3 trials
phase_1phase_2
fred-hutchinson-cancer-center
Multigated Acquisition Scan
2 trials
phase_1phase_2
fred-hutchinson-cancer-center

+22 more interventions

30 unique interventions4 categories

Analytics

Trial Phases

Phase 11
Phase 25

Trial Status

Completed2
Recruiting1
Terminated2
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT04083170Phase 2Terminated
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Acute Erythroid LeukemiaAcute Lymphoblastic LeukemiaAcute Megakaryoblastic Leukemia+8 more
PrincipalinvestigatorStart date: 2022-10-06
NCT03399773Phase 2Active Not Recruiting
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
PrincipalinvestigatorStart date: 2022-05-10
NCT04526288Phase 2Terminated
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Myeloid Neoplasm
PrincipalinvestigatorStart date: 2021-08-09
NCT04375631Phase 1Recruiting
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
PrincipalinvestigatorStart date: 2020-12-03
NCT01690520Phase 2Completed
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+2 more
PrincipalinvestigatorStart date: 2012-12-11
NCT00796068Phase 2Completed
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more
PrincipalinvestigatorStart date: 2009-02-24

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+2 more
Similarity Score5%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score5%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+2 more
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more
Similarity Score4%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score3%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute

Worked with same sponsors:

Jazz PharmaceuticalsNational Cancer Institute (NCI)+1 more
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04083170Phase 2PrincipalInvestigator

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Acute Erythroid LeukemiaAcute Lymphoblastic LeukemiaAcute Megakaryoblastic Leukemia+8 more
Terminated
NCT03399773Phase 2PrincipalInvestigator

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
Active Not Recruiting
NCT04526288Phase 2PrincipalInvestigator

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Myeloid Neoplasm
Terminated
NCT04375631Phase 1PrincipalInvestigator

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
Recruiting
NCT01690520Phase 2PrincipalInvestigator

Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+2 more
Completed
NCT00796068Phase 2PrincipalInvestigator

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more
Completed

All 6 trials loaded